Related by context. All words. (Click for frequent words.) 63 malignant glioma lethal 59 glioblastoma multiforme 57 glioblastoma 55 Glioblastoma multiforme 55 Glioblastoma 55 Glioblastoma multiforme GBM 55 malignant gliomas 53 Glioblastomas 53 glioblastoma multiforme GBM 52 astrocytomas 52 astrocytoma 52 Anaplastic 51 invasive ductal cancer 51 Glioblastoma Multiforme 51 malignant glioma brain tumor 51 non Hodgkin lymphoma 50 gastrointestinal stromal tumor 50 myelofibrosis polycythemia vera 50 MALT lymphoma 50 malignant brain tumor 50 grade gliomas 50 grade glioma 50 metastatic melanoma 50 Gliomas 50 neuroendocrine cancer 49 gliomas 49 glioblastomas 49 gastrointestinal stromal tumor GIST 49 medullary thyroid cancer 49 Malignant gliomas 49 postoperative pathology 49 glioma 49 gastrointestinal stromal tumors 49 Glioma 49 thymoma 49 lymphoma 49 anaplastic astrocytoma 49 B CLL 49 GISTs 49 Cholangiocarcinoma 49 seminoma 49 acute leukemias 48 anaplastic 48 brain tumor glioblastoma multiforme 48 papillary thyroid cancer 48 PCNSL 48 Pancreatic cancer 48 Myelofibrosis 48 Acute myeloid leukemia 48 neuroblastoma tumor 48 recurrent glioblastoma multiforme GBM 48 medulloblastoma 48 Chronic lymphocytic leukemia 48 ependymoma 48 chronic lymphocytic leukemia CLL 48 Hurthle cell 48 Malignant glioma 48 Basal cell 48 Metastatic 48 malignant pancreatic 47 neuroendocrine cancers 47 Non Hodgkin lymphoma 47 leukemias 47 lymphomas 47 Glioblastoma Multiforme GBM 47 myelodysplastic disorder 47 cell lymphoma 47 grade dysplasia 47 brain tumors 47 brain tumor 47 neuroendocrine tumors 47 Nephrogenic Systemic Fibrosis NSF 47 Follicular lymphoma 47 myelodysplastic syndrome MDS 47 carcinoid 47 Gleevec resistant 47 Multiple myeloma 47 Carcinoid tumors 47 thymic carcinoma 47 Kit CD# positive 47 Metastatic melanoma 47 pancreatic NET 47 pancreatic cancers 47 chronic myeloid leukemia 47 myeloproliferative neoplasms 47 paraganglioma 46 brain metastases 46 infection progressive multifocal 46 ADPKD 46 carcinoid cancer 46 glioblastoma GBM 46 ovarian lung 46 myelodysplastic syndromes 46 Wegener granulomatosis 46 cortical dysplasia 46 pancreatic adenocarcinoma 46 recurrent Hodgkin 46 differentiated thyroid 46 multiforme 46 AA amyloidosis 46 estrogen receptor negative 46 Gastric cancer 46 subependymal giant cell 46 cell carcinoma 46 recurrent glioblastoma multiforme 46 sarcoma 46 indolent lymphoma 46 ovarian breast 46 malignant brain 46 Hodgkin lymphoma NHL 46 acute promyelocytic leukemia 46 nonmelanoma skin cancers 46 recurrent NSCLC 46 leukemia AML 46 myeloproliferative disorders 46 Wilms tumor 46 breast carcinomas 46 malignant pleural mesothelioma 46 Moyamoya disease 46 bladder cancers 46 superficial bladder cancer 46 melanoma 46 nasopharyngeal carcinoma 45 basal cell carcinoma 45 Thyroid cancer 45 Philadelphia Chromosome Positive 45 frontotemporal dementia 45 GBMs 45 progressive multifocal leukoencephalopathy PML 45 adenoid cystic carcinoma 45 leiomyosarcoma 45 epithelial ovarian cancer 45 lymphocytic leukemia 45 allogeneic bone marrow 45 squamous cell cancer 45 unresectable tumors 45 leukemia APL 45 grade cervical intraepithelial 45 malignant neoplasm 45 K ras 45 metastatic cancer 45 idiopathic pulmonary fibrosis IPF 45 HER2 positive breast cancer 45 hematological diseases 45 Anal cancer 45 follicular lymphoma 45 oligodendroglioma 45 gallstone pancreatitis 45 basal cell carcinoma BCC 45 myeloid leukemia 45 KRAS wild 45 hepatorenal syndrome 45 Follicular Lymphoma 45 metastatic GIST 45 dermatofibrosarcoma protuberans 45 myelodysplastic syndrome 45 paroxysmal nocturnal hemoglobinuria PNH 45 pancreatic carcinoma 45 pheochromocytoma 45 Hepatocellular Carcinoma HCC 45 Hodgkin lymphoma HL 45 Mantle Cell Lymphoma 45 metastatic carcinoma 45 ZACTIMA TM ZD# 45 oligodendrogliomas 45 pre cancerous lesion 45 Chronic Lymphocytic Leukemia CLL 45 leukoencephalopathy 45 Burkitt lymphoma 45 synovial sarcoma 45 Medulloblastoma 45 acute promyelocytic leukemia APL 45 pancreatic islet cell 45 basal cell cancer 45 Niemann Pick disease 45 neuroblastoma 45 leukemia ALL 45 breast carcinoma 44 alveolar soft 44 recurrent ovarian cancer 44 fungoides 44 Merkel cell carcinoma 44 HER2 positive 44 ovarian tumors 44 chronic lymphocytic leukemia 44 cervical carcinoma 44 relapsed SCLC 44 malignant pheochromocytoma 44 malignancies 44 endometrial cancers 44 medically inoperable 44 malignant melanomas 44 myelosuppression 44 neurofibroma 44 epithelial tumors 44 Acute Myelogenous Leukemia 44 Myelodysplastic Syndrome 44 pancreatic tumor 44 acute lymphoblastic 44 diffuse gastric 44 medulloblastomas 44 Leukemias 44 metastatic 44 cell lymphomas 44 esophageal adenocarcinoma 44 metastatic kidney 44 arteriovenous malformations 44 juvenile myelomonocytic leukemia 44 Acute lymphoblastic leukemia 44 Uterine fibroids 44 pleural mesothelioma 44 colorectal cancer CRC 44 pituitary adenoma 44 colorectal lung 44 lung adenocarcinomas 44 leukemia CLL 44 Malignant melanoma 44 Amrubicin 44 cell lymphoma ALCL 44 systemic scleroderma 44 transfusion syndrome 44 Bladder cancer 44 Endometrial cancer 44 malignant lymphoma 44 medulloblastoma malignant brain tumor 44 malignancy 44 Malignant Melanoma 44 alveolar rhabdomyosarcoma 44 Ewing sarcoma 44 renal cell carcinomas 44 mycosis fungoides 44 sarcomas 44 recurrent glioblastoma 44 graft dysfunction 44 carcinoid tumors 44 lung cancer NSCLC 44 Chronic myeloid leukemia CML 44 cancerous brain tumor 44 HER2 positive cancers 44 EGFR targeting 44 refractory chronic lymphocytic 44 indolent NHL 44 angiosarcoma 44 metastatic colorectal 44 anti angiogenic therapy 44 atypical ductal hyperplasia 44 hepatocellular carcinoma HCC 44 candidemia 43 castration resistant prostate cancer 43 Bezielle 43 bone metastasis 43 lymph node metastases 43 castration resistant 43 polycythemia vera 43 relapsed refractory multiple myeloma 43 pegfilgrastim 43 hypophosphatasia 43 metastatic lung cancer 43 indolent follicular non 43 PARP inhibitors 43 refractory indolent non 43 colorectal liver 43 chronic myelogenous leukemia CML 43 cell sarcoma 43 familial adenomatous polyposis 43 Stomach cancer 43 Hodgkin disease 43 tumor 43 adenocarcinoma 43 invasive secretory carcinoma 43 renal carcinoma 43 epithelial ovarian 43 renal cell carcinoma 43 Sezary syndrome 43 pancytopenia 43 carcinoid tumor 43 peritoneal cancer 43 Carboplatin 43 lung tumors 43 neoplasm 43 Hepatocellular carcinoma 43 desmoid tumor 43 papillary carcinoma 43 Acute Myeloid Leukemia AML 43 common hematologic malignancy 43 malignant melanoma 43 colorectal liver metastases 43 pituitary adenomas 43 invasive breast cancer 43 nonsmall cell lung cancer 43 carcinomas 43 liver metastases 43 Pompe Disease 43 prostate adenocarcinoma 43 VIDAZA 43 peritoneal carcinomatosis 43 GIST tumors 43 pancreatic tumors 43 BRAF mutations 43 prostate cancers 43 colon cancer 43 GIST 43 atypical hyperplasia 43 histone deacetylase HDAC inhibitor 43 intracranial tumors 43 gastric adenocarcinoma 43 invasive ductal carcinoma 43 primitive neuroectodermal tumor 43 Non Hodgkins lymphoma 43 cutaneous T 43 acute myelogenous leukemia AML 43 Waldenstrom macroglobulinemia 43 Kaposi sarcoma 43 Ginsburg pancreas 43 myelofibrosis MF 43 invasive ductal 43 Tamibarotene 43 metastatic bladder 43 malignant lesions 43 chronic granulomatous disease 43 nasopharyngeal cancer 43 cutaneous squamous cell carcinoma 43 Alemtuzumab 43 tumors 43 malignant prostate 43 metastatic gastric 43 clinically localized prostate 43 precancerous cervical lesions 43 bladder tumors 43 Peritoneal mesothelioma 43 prostate pancreatic 43 allogeneic stem cell 43 CD# mAb 43 mycophenolate mofetil 43 carcinoma 43 metastatic colon cancer 43 PNP inhibitor 43 Chronic lymphocytic leukemia CLL 43 endocrine tumors 43 vandetanib 43 fallopian tube carcinoma 43 Squamous 43 hematologic disorders 43 pilocytic astrocytoma 43 bladder ovarian 43 myelofibrosis 43 pancreatic cancer 43 recurrent colorectal cancer 43 cancerous lesions 42 metastatic malignant melanoma 42 lymphoma Hodgkin lymphoma 42 operable breast cancer 42 gastric carcinoma 42 JMML 42 malignant fibrous histiocytoma 42 cholangiocarcinoma rare 42 neurodegenerative disorder 42 myelodysplastic syndromes MDS 42 follicular lymphoma FL 42 sarcomatoid 42 poorer prognosis 42 IV metastatic melanoma 42 erlotinib Tarceva ® 42 axillary lymph nodes 42 renal tumors 42 adenoma 42 superficial basal cell carcinoma 42 BRAF V# mutation 42 cell acute lymphoblastic 42 metastatic brain tumor 42 pediatric malignancies 42 non squamous 42 imatinib Gleevec 42 cirrhosis liver failure 42 Amyotrophic lateral sclerosis ALS 42 hepatocellular carcinomas 42 bile duct cancers 42 lobular carcinoma 42 meningiomas 42 Colorectal cancer CRC 42 systemic amyloidosis 42 neuronal ceroid lipofuscinosis NCL 42 leukaemias 42 metastatic liver 42 Meningiomas 42 systemic anaplastic large 42 temozolomide Temodar 42 colorectal polyps 42 receptor tyrosine kinase inhibitor 42 essential thrombocythemia 42 refractory Hodgkin lymphoma 42 acute myeloid leukemia 42 IV melanoma 42 HNPCC 42 cell carcinomas 42 Wilm Tumor 42 colorectal breast 42 pulmonary metastases 42 rhabdomyosarcoma 42 mucinous 42 Melanoma 42 neoplasms 42 falciparum malaria 42 necrotizing pneumonia 42 Basal cell carcinoma 42 TEMODAL 42 acute myeloid 42 hematopoietic malignancies 42 neuroblastomas 42 unresectable 42 metastatic lesions 42 smoldering myeloma 42 Cell Lymphoma 42 metastatic colorectal cancer 42 Infusion reactions 42 hematological 42 fibroadenomas 42 hematologic malignancies 42 ovarian cancer 42 recurrent GBM 42 familial amyloidotic polyneuropathy FAP 42 DCIS lesions 42 breast tumors 42 Parkinson disease neurodegenerative disorder 42 idiopathic thrombocytopenic purpura 42 gastrointestinal cancers 42 meningioma 42 ovarian tumor 42 hemophagocytic lymphohistiocytosis 42 Inhaled anthrax 42 lymphoma CTCL 42 unclassified myeloproliferative disorder 42 olaparib 42 inherited neurodegenerative disorder 42 Epratuzumab 42 benign breast 42 advanced hepatocellular carcinoma 42 Carcinoma 42 thyroid cancer 42 curable cancers 42 severe neutropenia 42 recurrent glioma 42 pulmonary hypertension PH 42 relapsing remitting MS RRMS 42 Wilms tumors 42 DIPG 42 Alessandro Riva 42 grade serous ovarian 42 supratentorial 42 multiple endocrine neoplasia 42 cancer mCRC 42 radiation chemoradiation 42 Metastatic colorectal cancer 42 urothelial cancer 42 temsirolimus 42 Epstein Barr virus EBV 42 small lymphocytic lymphoma 42 cutaneous T cell 42 primitive neuroectodermal tumors 42 Gleevec imatinib 42 5-fluorouracil/leucovorin 42 relapsing remitting multiple sclerosis 42 neurofibromas 42 Neutropenia 42 chronic myeloid 42 malignant neoplasms 42 anaplastic thyroid cancer 42 serous ovarian cancer 42 ductal adenocarcinoma 42 chronic myelogenous leukemia 42 1 diabetes T1D 42 HGPS 42 gastrointestinal stromal tumors GIST 42 CMV infection 42 cancer 42 cell lymphoma CTCL 42 precursor lesions 42 liver metastasis 42 Cryptococcus neoformans 42 pancreatic neuroendocrine tumors 42 arteriovenous malformation 42 histologies 42 Omacetaxine 42 lymphatic tissue 42 gastrointestinal stromal 42 BRAF gene 42 colon polyps 42 dyskeratosis congenita 42 Chronic Lymphocytic Leukemia 42 cholangiocarcinoma 42 interstitial pulmonary fibrosis 42 relapsed multiple myeloma 42 osteosarcoma rare 41 metastatic cancers 41 cilengitide 41 squamous cell 41 Adjuvant chemotherapy 41 ischemic colitis 41 HNSCC 41 cranial radiation 41 malignant tumor 41 locoregional 41 pan HDAC inhibitor 41 pemphigus vulgaris 41 gastric cancers 41 idiopathic thrombocytopenic purpura ITP 41 non Hodgkin lymphomas 41 acoustic neuromas 41 Wilms Tumor 41 neoadjuvant therapy 41 chronic myeloid leukemia CML 41 tumoral 41 ALCL 41 B Cell Lymphoma 41 axillary dissection 41 Pleural mesothelioma 41 Radical prostatectomy 41 non metastatic osteosarcoma 41 malignant growths 41 IV NSCLC 41 cisplatin resistant 41 T#I mutant 41 intestinal polyps 41 squamous cell carcinoma SCC 41 breast cancers 41 DCIS 41 radiolabeled TM# 41 esophagitis 41 ductal carcinoma 41 Acute Myelogenous Leukemia AML 41 NSCLC 41 prostate tumor 41 trans retinoic acid 41 acute leukemia 41 CIN3 41 myeloproliferative diseases 41 lymphocytic 41 cytogenetic responses 41 thyroid tumors 41 pre cancerous 41 premalignant lesions 41 hematological malignancies 41 hepatocellular carcinoma 41 ccRCC 41 sunitinib Sutent 41 dasatinib Sprycel ® 41 systemic lupus erythematosus 41 bronchogenic carcinoma 41 stage IIIb 41 non hodgkin lymphoma 41 metastatic prostate cancer 41 hypereosinophilic syndrome 41 adenocarcinomas 41 NSF NFD 41 Non Hodgkin Lymphoma 41 Non Hodgkin 41 BRCA mutations 41 prostate carcinomas 41 imatinib Gleevec ® 41 myeloablative 41 Idiopathic Pulmonary Fibrosis IPF 41 EGFR inhibitors 41 Candida infections 41 relapsed leukemia 41 chronic HBV infection 41 MPGN 41 tumors GIST 41 AAT deficiency 41 prostate cancer 41 malignant lymphomas 41 non metastatic resectable 41 advanced adenomas 41 refractory multiple myeloma 41 Takotsubo cardiomyopathy 41 chemotherapy cisplatin 41 inoperable pancreatic cancer 41 HER2 positive metastatic breast 41 Pemetrexed 41 aHUS 41 fatal neuromuscular disorder 41 Vidofludimus 41 thyroid nodules 41 Osteosarcoma 41 radiation sensitizer 41 dasatinib Sprycel 41 basal cell 41 Chronic sinusitis 41 Leber congenital amaurosis LCA 41 oral clodronate 41 benign proliferative breast 41 colorectal carcinoma 41 familial ALS 41 invasive aspergillosis 41 beta thalassemia 41 acute humoral rejection 41 myeloproliferative disorder 41 embryonal rhabdomyosarcoma 41 Castration Resistant Prostate Cancer 41 Zolinza 41 cytoreductive surgery 41 metastatic renal cell carcinoma 41 bleomycin 41 Belldegrun 41 T Cell Lymphoma 41 Hodgkin Disease 41 cell chronic lymphocytic 41 endometrial carcinoma 41 incurable neurological disorder 41 degenerative neurological condition 41 EXJADE 41 Ewing Sarcoma 41 ovarian cancers 41 endometrial hyperplasia 41 leukemia CML 41 Liver Cancer 41 Idiopathic Pulmonary Fibrosis 41 chemotherapeutic agent 41 xenograft models 41 Multiple Myeloma 41 Psoriatic arthritis 41 biliary cancer 41 cervical intraepithelial neoplasia 41 Aplastic anemia 41 glioblastoma brain tumor 41 leukemia lymphoma multiple myeloma 41 liver cancer 41 BRCA1 mutations 41 Barrett esophagus 41 hematopoietic cancers 41 pheochromocytomas 41 Cutaneous T 41 vascular abnormalities 41 acute myeloid leukemia AML 41 gefitinib Iressa 41 BAY #-# 41 sorafenib Nexavar 41 intestinal inflammation 41 renovascular hypertension 41 lymphatic cancer 41 Pancreatic neuroendocrine tumors 41 histologic subtype 41 relapsed MM 41 Cell Non Hodgkin 41 motor neuron diseases 41 progressive neurodegenerative disorder 41 standard chemotherapy regimens 41 prostate cancer PCa 41 paragangliomas 41 tumor recurrence 41 lung metastases 41 refractory acute myeloid 41 primary immunodeficiency PI 41 hemolytic anemia 41 Colorectal cancers 41 relapsed GBM 41 Peritoneal Mesothelioma 41 Trastuzumab 41 localized renal 40 Diffuse Large B 40 prophylactic cranial irradiation 40 distant metastasis 40 acute lymphoid leukemia 40 malignant cancerous 40 lung adenocarcinoma 40 choriocarcinoma 40 carcinoma mCRC 40 Chronic Myeloid Leukemia CML 40 depsipeptide 40 advanced metastatic prostate 40 advanced metastatic renal 40 debilitating neurodegenerative 40 blood clotting disorder 40 metastatic ovarian cancer 40 relapsing remitting 40 metastatic disease 40 galiximab 40 nodular melanoma 40 metastatic adenocarcinoma 40 cytoreduction 40 chronic ITP 40 testicular cancers 40 angiogenesis inhibition 40 pancreatic 40 PNET 40 Waldenstrom Macroglobulinemia 40 diffuse intrinsic pontine glioma 40 acute lymphoblastic leukemia 40 follicular thyroid cancer 40 fibrous dysplasia 40 CYT# potent vascular disrupting 40 acute coronary syndromes ACS 40 chronic lymphocytic 40 castrate resistant prostate cancer 40 TACE 40 prostate lung 40 papillary 40 colorectal cancer 40 neoplasias 40 Colorectal cancer 40 Polycythemia vera 40 neuro endocrine tumors 40 frontotemporal lobar degeneration 40 Metastatic Colorectal Cancer 40 IMGN# 40 CMV disease 40 noncancerous 40 ovarian carcinoma 40 Acute Leukemia 40 Ovarian cancer 40 colorectal adenocarcinoma 40 benign tumors 40 Malignant mesothelioma 40 cervical dysplasia 40 lung pancreatic 40 noncancerous tumors 40 Melanomas 40 Rhabdomyosarcoma 40 Epithelial ovarian cancer 40 benign nodules 40 aplastic anemia 40 eosinophilic esophagitis 40 Esophageal cancer 40 squamous cell lung cancer 40 dasatinib 40 Sentinel node biopsy 40 Clofarabine 40 pancreas colon 40 infantile hemangiomas 40 cell malignancies 40 hematological cancers 40 mesotheliomas 40 unresectable stage 40 EGFr 40 Hodgkin Lymphoma 40 heterozygous FH 40 LQTS 40 hamartomas 40 thalidomide Thalomid 40 MabCampath 40 myotonic muscular dystrophy 40 rituximab Rituxan 40 PNH 40 systemic lupus erythematosus SLE 40 urothelial carcinoma 40 diagnosed glioblastoma multiforme 40 ovarian pancreatic 40 tumor lysis syndrome 40 Brain metastases 40 prostate carcinoma 40 inherited metabolic disorders 40 colorectal cancers 40 refractory peripheral T 40 Vectibix 40 invasive ductal breast cancer 40 palliative radiotherapy 40 cancers 40 colon tumors 40 efalizumab 40 Hodgkin lymphomas 40 thoracic aortic disease 40 antigen PSA 40 retinoblastoma 40 soft tissue sarcomas 40 Leukemia AML 40 gastrointestinal GI cancers 40 gynecologic malignancy 40 taxanes 40 MGUS 40 Prostatitis 40 systemic ALCL 40 Cerebral malaria 40 obstructed bile duct 40 polyps growths 40 transitional cell carcinoma 40 distant metastases 40 leukemia myeloma 40 FOLFOX4 40 hypoxia inducible factor 40 follicular non 40 follicular NHL 40 von Willebrand disease 40 Acute Myeloid Leukaemia 40 Stereotactic radiosurgery 40 uterine cancers 40 mutated BRAF gene 40 mCRC 40 cutaneous melanoma 40 pancreatic colon 40 nonalcoholic steatohepatitis NASH 40 Hutchinson Gilford Progeria Syndrome 40 malignant 40 prostate gland 40 oropharyngeal cancer 40 myeloma cells 40 tyrosine kinase inhibitors 40 MYCN amplification 40 Advanced Renal Cell 40 refractory systemic anaplastic 40 romiplostim 40 metastatic renal cell 40 metastases 40 rhabdoid 40 blastoma 40 Myelodysplastic syndrome 40 refractory acute promyelocytic 40 ependymomas 40 osteosarcomas 40 neuro degenerative disorder 40 fatal neurodegenerative 40 acute myelogenous 40 myelogenous leukemia 40 Velculescu 40 pilocytic astrocytomas 40 endoscopy procedure 40 urinary bladder cancer 40 refractory NSCLC 40 Gorlin syndrome 40 Malignant tumors 40 pre cancerous lesions 40 taxane therapy 40 primary pulmonary hypertension 40 Testicular cancer 40 metastatic tumors 40 nilotinib 40 histological subtype 40 anthracyclines 40 malignant polyp 40 CLL cells 40 pancreatic neuroendocrine 40 delayed CINV 40 squamous cell cancers 40 lumbar disk herniation 40 Langerhans cell histiocytosis 40 rectal cancers 40 febrile neutropenia 40 nonmetastatic 40 temozolomide 40 hypercalcemia 40 commercialize deforolimus 40 node metastases 40 parathyroid 40 Arranon 40 hormone receptor positive 40 Folfox 40 precancerous lesions 40 neuroblastoma cells 40 squamous 40 myelodysplasia 40 metastatic carcinoid 40 cell lymphoma PTCL 40 hepatitis C genotype 40 cancerous tumors 39 FTLD 39 Adenoid Cystic Carcinoma 39 Acute myeloid leukemia AML 39 inflammatory myofibroblastic tumor 39 Cytoxan 39 lung cancers 39 fibrocystic disease 39 AAT Deficiency 39 pleural effusions 39 Lymphomas 39 Relapsed Refractory 39 interferon alfa 39 lymphoma subtypes 39 curative resection 39 fluorouracil 39 Renal cell carcinoma 39 adrenocortical carcinoma 39 cetuximab Erbitux 39 Vicinium TM 39 primary immunodeficiencies 39 Squamous cell 39 fungal meningitis 39 multiple myeloma 39 micrometastases 39 premalignant 39 Pompe disease 39 hematopoietic disorders 39 AA Amyloidosis 39 pancreatic colorectal 39 metastasis 39 tumor shrinkage 39 postherpetic neuralgia 39 Medullary thyroid cancer 39 mutated KRAS 39 epirubicin 39 Astrocytoma 39 gastric cancer 39 lung carcinomas 39 polycythemia vera PV 39 noncancerous brain tumor 39 Crigler Najjar syndrome 39 Irinotecan 39 ER CHOP 39 chronic plaque psoriasis 39 testicular tumor 39 ductal breast cancer 39 medulla blastoma 39 Oesophageal cancer 39 hematologic 39 metastatic sarcoma 39 ipsilateral breast 39 Relapsing remitting MS 39 dysentery bursitis 39 doxorubicin Adriamycin 39 eosinophilic pneumonia 39 Evoltra ® 39 BRCA deficient 39 metachronous 39 chronic lymphatic leukemia 39 refractory CTCL 39 gastric lymphoma 39 stage IIIA 39 investigational monoclonal antibody 39 radiation therapy SBRT 39 IgG1 monoclonal antibody 39 Pralatrexate 39 Liver transplants 39 cervical lesions 39 lymphoid malignancies 39 Li Fraumeni 39 pelvic malignancies 39 colon pancreatic 39 Bortezomib 39 EGFR tyrosine kinase inhibitors 39 Hodgkin lymphoma 39 Hashimoto thyroiditis 39 GvHD 39 leukemias lymphomas 39 Ewings Sarcoma 39 PTLD 39 colon cancers 39 lymphoblastic lymphoma 39 relapsed refractory aggressive 39 ixabepilone 39 immune modulator 39 SEER database 39 gynecologic cancers 39 PSADT 39 Relapsed Refractory Aggressive 39 trigeminal neuralgia 39 infantile onset 39 narcolepsy cataplexy 39 mCRC patients 39 lymphoblastic leukemia 39 Chronic myeloid leukemia 39 vinorelbine 39 Nexavar tablets 39 ductal carcinomas 39 uterine fibroid 39 pancreatic ductal adenocarcinoma 39 Romiplostim 39 squamous cell carcinoma 39 Pulmonary fibrosis 39 Dasatinib 39 immune thrombocytopenic purpura 39 uterine tumors 39 hematological malignancy 39 breast pancreatic 39 SCCHN 39 Cell Lung Cancer 39 pseudotumor cerebri 39 HER2 overexpression 39 YONDELIS 39 human papillomavirus HPV 39 glioblastoma tumors 39 hepatoblastoma 39 Inflammatory breast cancer 39 DAVANAT 39 hereditary predisposition 39 cavernous malformation 39 relapsed ovarian cancer 39 invasive bladder 39 Alzheimer disease AD 39 HER2 + 39 aortic rupture 39 familial pancreatic cancer 39 primary peritoneal 39 advanced adenoma 39 tumor metastases 39 huN# DM1 39 lymphoproliferative disorders 39 infantile spasms 39 Jack Linkletter 39 cerebral vascular disease 39 invasive lobular 39 breast ovarian 39 Onco TCS 39 neoplasia 39 Acute Myeloid Leukaemia AML 39 Retinopathy 39 Dr. Victor Velculescu 39 hemangiomas 39 leukemia 39 acute myelogenous leukemia 39 Toxicities 39 figitumumab 39 esthesioneuroblastoma rare form